🦊/Investors

YF CapitalFull Portfolio

7 tracked investments · listed companies and verified rows first

Accutar Biotechaccutarbio.cominApr 2021

US biotech using AI-driven computational design plus wet-lab validation to discover small-molecule oncology drugs.

BiotechNew York, US

Jie Fan(Founder)inWei He(Executive Officer)Yimin Qian(Executive Officer)Xiangyan Sun(Executive Officer)Quan Zhou(Director)Long Zhu(Director)

Co-investorsCoatue ManagementMorningside Venture Capital Limited

Asierisasieris.cnin𝕏

Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer.

BiotechFemTechMedical Devices

Co-investorsQiming Venture PartnersTriWise Capital

Axbioaxbio.comJun 2022

A life sciences company offering nanopore sequencing instruments and automated library preparation systems for molecular biology research.

BiotechDeep TechHardwareMedical DevicesSemiconductors

Co-investorsFoothill VenturesCBC Group

Dtyunxidtyunxi.comOct 2021 · $100M

Provider of enterprise-grade AI-native multi-agent solutions that deliver an "AI operations team" capable of autonomously driving business growth.

AI & Machine LearningEnterprise SoftwareSaaS

Galy Lee(Founder)

Co-investorsXiang He Capital

Momentamomenta.ai

Momenta develops autonomous driving software for automakers, offering L2/L2+ assisted driving and L3 autonomous driving systems for mass-produced vehicles.

AI & Machine LearningDeep TechMobility & TransportationRoboticsBeijing, CN

Co-investorsBlue Lake CapitalCathay InnovationGranite AsiaNIO CapitalShunwei CapitalBlackRock+2 more

Qiniuqiniu.com

Qiniu Cloud provides content moderation services for images, videos, audio, text, and live streams, automatically detecting and filtering prohibited content including adult material, violence, sensitive persons, ads, and malicious scenes.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareMedia & EntertainmentSaaSShanghai, CN

Co-investorsQiming Venture PartnersTitanium VenturesAlibaba GroupChina Structural Reform Fund

Sironaxsironax.comin𝕏Aug 2022 · $200M

Sironax is a biopharmaceutical company focused on the discovery and development of therapies for neurodegenerative, inflammatory and immunological, metabolic, and rare diseases.

BiotechHealthtechLongevityWaltham, US

Dr. Xiaodong Wang(Founder)Dr. Zhiyuan Zhang(Founder)

Co-investorsARCH Venture PartnersF-Prime CapitalYuanBio Venture CapitalCBC GroupEight Roads VenturesFuture Innovation+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.